Hemorrhagic Complications of Anticoagulant Treatment
Mark N. Levine(Juravinski Cancer Centre), Sam Schulman(Thrombosis and Atherosclerosis Research Institute), Clive Kearon(McMaster University), Rebecca J. Beyth(University of Florida), Gary E. Raskob(University of Oklahoma Health Sciences Center)
Cited by 513
Related Papers
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
|Journal of Thrombosis and Haemostasis|2009|3.8k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
|New England Journal of Medicine|2009|2.6k